1721. Acupuncture and Doxylamine-Pyridoxine for Nausea and Vomiting in Pregnancy : A Randomized, Controlled, 2 × 2 Factorial Trial.
作者: Xiao-Ke Wu.;Jing-Shu Gao.;Hong-Li Ma.;Yu Wang.;Bei Zhang.;Zhao-Lan Liu.;Jian Li.;Jing Cong.;Hui-Chao Qin.;Xin-Ming Yang.;Qi Wu.;Xiao-Yong Chen.;Zong-Lin Lu.;Ya-Hong Feng.;Xue Qi.;Yan-Xiang Wang.;Lan Yu.;Ying-Mei Cui.;Chun-Mei An.;Li-Li Zhou.;Yu-Hong Hu.;Lu Li.;Yi-Juan Cao.;Ying Yan.;Li Liu.;Yu-Xiu Liu.;Zhi-Shun Liu.;Rebecca C Painter.;Ernest H Y Ng.;Jian-Ping Liu.;Ben Willem J Mol.;Chi Chiu Wang.
来源: Ann Intern Med. 2023年176卷7期922-933页
An effective and safe treatment for nausea and vomiting of pregnancy (NVP) is lacking.
1723. Effect of Low-Dose Aspirin Versus Placebo on Incidence of Anemia in the Elderly : A Secondary Analysis of the Aspirin in Reducing Events in the Elderly Trial.
作者: Zoe K McQuilten.;Le Thi Phuong Thao.;Sant-Rayn Pasricha.;Andrew S Artz.;Michael Bailey.;Andrew T Chan.;Harvey Jay Cohen.;Jessica E Lockery.;Anne M Murray.;Mark R Nelson.;Hans G Schneider.;Rory Wolfe.;Robyn L Woods.;Erica M Wood.;John J McNeil.
来源: Ann Intern Med. 2023年176卷7期913-921页
Daily low-dose aspirin increases major bleeding; however, few studies have investigated its effect on iron deficiency and anemia.
1724. Clinical Characteristics and Outcomes Among Travelers With Severe Dengue : A GeoSentinel Analysis.
作者: Ralph Huits.;Kristina M Angelo.;Bhawana Amatya.;Sapha Barkati.;Elizabeth D Barnett.;Emmanuel Bottieau.;Hannah Emetulu.;Loïc Epelboin.;Gilles Eperon.;Line Medebb.;Federico Gobbi.;Martin P Grobusch.;Oula Itani.;Sabine Jordan.;Paul Kelly.;Karin Leder.;Marta Díaz-Menéndez.;Nobumasa Okumura.;Aisha Rizwan.;Camilla Rothe.;Mauro Saio.;Jesse Waggoner.;Yukihiro Yoshimura.;Michael Libman.;Davidson H Hamer.;Eli Schwartz.
来源: Ann Intern Med. 2023年176卷7期940-948页
Dengue virus is a flavivirus transmitted by Aedes mosquitoes and is an important cause of illness worldwide. Data on the severity of travel-associated dengue illness are limited.
1725. How Would You Manage This Patient With Recurrent Diverticulitis? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
作者: Howard Libman.;Judy W Nee.;Anthony J Lembo.;Risa B Burns.
来源: Ann Intern Med. 2023年176卷6期836-843页
Acute diverticulitis, which refers to inflammation or infection, or both, of a colonic diverticulum, is a common medical condition that may occur repeatedly in some persons. It most often manifests with left-sided abdominal pain, which may be associated with low-grade fever and other gastrointestinal symptoms. Complications may include abscess, fistula formation, perforation, and bowel obstruction. The American College of Physicians recently published practice guidelines on the diagnosis and management of acute diverticulitis, the role of colonoscopy after resolution, and interventions to prevent recurrence of this condition. Among the recommendations were the use of abdominal computed tomography (CT) scanning in cases where there was diagnostic uncertainty, initial management of uncomplicated cases in the outpatient setting without antibiotics, referral for colonoscopy after an initial episode if not performed recently, and discussion of elective surgery to prevent recurrent disease in patients with complicated diverticulitis or frequent episodes of uncomplicated disease. Here, 2 gastroenterologists with expertise in acute diverticulitis debate CT scanning for diagnosis, antibiotics for treatment, colonoscopy to screen for underlying malignancy, and elective surgery to prevent recurrent disease.
1726. Dyslipidemia.
Dyslipidemia is an important risk factor for coronary artery disease and stroke. All persons with dyslipidemia should be advised to focus on lifestyle interventions, including regular aerobic exercise, a healthy diet, maintenance of a healthy weight, and abstinence from smoking. In addition to lifestyle interventions, lipid-lowering therapy should be considered for persons at moderate to high risk for atherosclerotic cardiovascular disease based on validated risk equations. Statin therapy is the first-line medical treatment for dyslipidemia due to its effectiveness and favorable adverse effect profile, but newer treatments provide additional tools for clinicians to effectively treat dyslipidemia.
1728. Treatment of Fetal Cystic Fibrosis With Cystic Fibrosis Transmembrane Conductance Regulator Modulation Therapy.
作者: Yair J Blumenfeld.;Susan R Hintz.;Natali Aziz.;Richard A Barth.;Jacquelyn M Spano.;Yasser Y El-Sayed.;Carlos Milla.
来源: Ann Intern Med. 2023年176卷7期1015-1016页 1732. In older adults, an Ad26.RSV.preF-RSV preF protein vaccine reduced RSV-related lower respiratory tract disease.
Falsey AR, Williams K, Gymnopoulou E, et al; CYPRESS Investigators. Efficacy and safety of an Ad26.RSV.preF-RSV preF protein vaccine in older adults. N Engl J Med. 2023;388:609-620. 36791161.
1734. After ICH, starting long-term therapeutic oral anticoagulation in patients with AF reduces MACE at 1 to 3 y.
Cochrane A, Chen C, Stephen J, et al. Antithrombotic treatment after stroke due to intracerebral haemorrhage. Cochrane Database Syst Rev. 2023;1:CD012144. 36700520.
1735. In TB, an 8-wk, 5-drug regimen was noninferior to a standard 24-wk, 4-drug regimen for clinical outcomes at 96 wk.
Paton NI, Cousins C, Suresh C, et al; TRUNCATE-TB Trial Team. Treatment strategy for rifampin-susceptible tuberculosis. N Engl J Med. 2023;388:873-887. 36808186.
1736. In severe tricuspid regurgitation, tricuspid TEER improved QoL more than medical therapy at 1 y.
Sorajja P, Whisenant B, Hamid N, et al; TRILUMINATE Pivotal Investigators. Transcatheter repair for patients with tricuspid regurgitation. N Engl J Med. 4 Mar 2023. [Epub ahead of print]. 36876753.
1737. In older adults, an AS01E-adjuvanted RSVPreF3 OA vaccine reduced RSV-related lower respiratory tract disease.
Papi A, Ison MG, Langley JM, et al; AReSVi-006 Study Group. Respiratory syncytial virus prefusion F protein vaccine in older adults. N Engl J Med. 2023;388:595-608. 36791160.
1738. Genotype-guided drug prescribing vs. usual care reduced clinically relevant adverse drug reactions at 12 wk.
Swen JJ, van der Wouden CH, Manson LE, et al; Ubiquitous Pharmacogenetics Consortium. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. Lancet. 2023;401:347-356. 36739136.
1740. P2Y12 inhibitor monotherapy 1 to 3 mo after PCI did not differ from standard DAPT for fatal or ischemic events.
Gragnano F, Mehran R, Branca M; Single Versus Dual Antiplatelet Therapy (Sidney-2) Collaboration. P2Y12 inhibitor monotherapy or dual antiplatelet therapy after complex percutaneous coronary interventions. J Am Coll Cardiol. 2023;81:537-552. 36754514.
|